Embryonic Stem Cells for Osteo-Degenerative Diseases

11Citations
Citations of this article
185Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Current orthopedic practice to treat osteo-degenerative diseases, such as osteoporosis, calls for antiresorptive therapies and anabolic bone medications. In some cases, surgery, in which metal rods are inserted into the bones, brings symptomatic relief. As these treatments may ameliorate the symptoms, but cannot cure the underlying dysregulation of the bone, the orthopedic field seems ripe for regenerative therapies using transplantation of stem cells. Stem cells bring with them the promise of completely curing a disease state, as these are the cells that normally regenerate tissues in a healthy organism. This chapter assembles reports that have successfully used stem cells to generate osteoblasts, osteoclasts, and chondrocytes – the cells that can be found in healthy bone tissue – in culture, and review and collate studies about animal models that were employed to test the function of these in vitro “made” cells. A particular emphasis is placed on embryonic stem cells, the most versatile of all stem cells. Due to their pluripotency, embryonic stem cells represent the probably most challenging stem cells to bring into the clinic, and therefore, the associated problems are discussed to put into perspective where the field currently is and what we can expect for the future.

Cite

CITATION STYLE

APA

Nieden, N. I. zur. (2010). Embryonic Stem Cells for Osteo-Degenerative Diseases. In Methods in Molecular Biology (Vol. 690, pp. 1–30). Humana Press Inc. https://doi.org/10.1007/978-1-60761-962-8_1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free